Presentations

Symposium Talk. AMP Schizophrenia: Clinically Actionable Lessons from the Largest and Ongoing Study of Clinical High Risk for Psychosis. APA Annual Meeting 2025. Wolff, P. M.

Symposium Talk. Utilizing Generative AI for Early Detection of Psychosis: Linguistic Feature Clustering and Risk Differentiation in CHR Populations. SIRS 2025. Wolff, P. M., & Bilgrami, Z. R.

Symposium Talk. Utilizing Generative AI for Early Detection of Psychosis: Linguistic Feature Clustering and Risk Differentiation in CHR Populations. SIRS 2025. Wolff, P.

Poster. Automated Assessment of Language Concreteness in Clinical High-Risk and Healthy Control Speech Using Large Language Models. SIRS 2025 (Late Breaking). Bilgrami, Z., Dixon, B., & Wolff, P.

Oral Presentation. Leveraging AI to Predict Psychosis Risk in Clinical High-Risk Individuals. SOBP 2025. Wolff, P. M., Bilgrami, Z. R., Corcoran, C. M., & Cecchi, G. A.

Symposium Talk. Leveraging AI and Language Analysis to Predict Psychosis Risk in Clinical High-Risk Individuals. SOBP 2025. Wolff, P.

Poster. ANNA-PR: A Novel AI-Driven Platform for Automating Psychosis Risk Assessment. SOBP 2025 (Late Breaking). Mourgues, C., Woods, S., & Wolff, P.

Poster. Generative AI-Enhanced Language Analysis for Early Detection of Psychosis Risk. ISCTM 2025. Wolff, P. M., Bilgrami, Z. R., Cecchi, G. A., Corcoran, C. M., Nelson, B., Shenton, M. E., & Woods, S. W.

Poster. Leveraging Generative AI to Identify Linguistic Biomarkers of Psychosis Risk. ACNP 2024. Bilgrami, Z. R., Corcoran, C. M., Nelson, B., Woods, S. W., Shenton, M. E., Kahn, R., McGorry, P., Kane, J., Bearden, C., Cecchi, G. A., Pandina, G., Wolff, P. M., & Accelerating Medicines Partnership Schizophrenia (AMP SCZ).

Poster. Using Large Language Models to Automate the Redaction of Personal Identifiable Information (PII) from Natural Language Transcripts. TIPS 2024. Wolff, P.

Symposium Talk. Using Large Language Models to Understand Disorders and Predict Psychosis. TIPS 2024. Bilgrami, Z. R., Wolff, P., Walker, E., & Accelerating Medicines Partnership Schizophrenia (AMP SCZ).